Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119153164 | 11915316 | 4 | F | 20130717 | 20160629 | 20160114 | 20160708 | EXP | CA-ROCHE-1692996 | ROCHE | 56.86 | YR | M | Y | 0.00000 | 20160708 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119153164 | 11915316 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 300 MG, EVERY 4 WEEKS | U | S0001E | 103976 | 300 | MG | SOLUTION FOR INJECTION | |||||
| 119153164 | 11915316 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0001E | 103976 | 300 | MG | |||||||
| 119153164 | 11915316 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0001E | 103976 | |||||||||
| 119153164 | 11915316 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0001E | 103976 | |||||||||
| 119153164 | 11915316 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0001E | 103976 | |||||||||
| 119153164 | 11915316 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0001E | 103976 | |||||||||
| 119153164 | 11915316 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0001E | 103976 | |||||||||
| 119153164 | 11915316 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0001E | 103976 | |||||||||
| 119153164 | 11915316 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0001E | 103976 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119153164 | 11915316 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119153164 | 11915316 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119153164 | 11915316 | Abdominal pain | |
| 119153164 | 11915316 | Asthma | |
| 119153164 | 11915316 | Blood pressure increased | |
| 119153164 | 11915316 | Cough | |
| 119153164 | 11915316 | Dermatitis | |
| 119153164 | 11915316 | Diarrhoea | |
| 119153164 | 11915316 | Discomfort | |
| 119153164 | 11915316 | Ear infection | |
| 119153164 | 11915316 | Fatigue | |
| 119153164 | 11915316 | Gait disturbance | |
| 119153164 | 11915316 | Headache | |
| 119153164 | 11915316 | Heart rate increased | |
| 119153164 | 11915316 | Lung infection | |
| 119153164 | 11915316 | Nasal congestion | |
| 119153164 | 11915316 | Nasal discharge discolouration | |
| 119153164 | 11915316 | Nasopharyngitis | |
| 119153164 | 11915316 | Oropharyngeal pain | |
| 119153164 | 11915316 | Pain | |
| 119153164 | 11915316 | Road traffic accident | |
| 119153164 | 11915316 | Sinus pain | |
| 119153164 | 11915316 | Sinusitis | |
| 119153164 | 11915316 | Spinal fracture | |
| 119153164 | 11915316 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119153164 | 11915316 | 1 | 20060406 | 0 | ||
| 119153164 | 11915316 | 2 | 20090416 | 0 | ||
| 119153164 | 11915316 | 3 | 20130717 | 0 | ||
| 119153164 | 11915316 | 4 | 20140910 | 0 | ||
| 119153164 | 11915316 | 5 | 20141008 | 0 | ||
| 119153164 | 11915316 | 6 | 20151111 | 0 | ||
| 119153164 | 11915316 | 7 | 20160106 | 0 | ||
| 119153164 | 11915316 | 8 | 20160525 | 0 | ||
| 119153164 | 11915316 | 9 | 20160629 | 0 |